Clinical Management of Suspected or Confirmed COVID-19 Disease Version 5 (24 August 2020) - UPDATED
These guidelines describe the clinical management of cases of COVID-19 disease, including clinical care in and outside of health facilities, and are intended for use in both public had private sectors. The guidelines are developed by the Clinical Guidelines Subcommittee of the National Department of Health’s Incident Management Team. They are informed by rapid medicine reviews conducted by the National Essential Medicines List Committee’s Subcommittee on COVID-19, as well as advisories provided by the Ministerial Advisory Committee on COVID-19. The following sections/modules have been updated or added as annexures to the current guideline:
• Module 1 – Epidemiology and clinical characteristics (module updated)
• Module 11 – Long-COVID (new module)
The guidelines are presented as 11 modules in order to facilitate and expedite updating of individual sections in future.
The National Department of Health is committed to providing regular updates for guidelines, as knowledge regarding strategies to address COVID-19 develop both globally and in South Africa.